Fast updates from the world of phages, viromes, and microbiome science.
Phagos, a French biotechnology company pioneering AI-powered phage therapy, has raised €25 million (US$29 million) in a Series A funding round to accelerate its antibiotic-free solutions…
In a groundbreaking medical achievement, doctors from Guntur, Andhra Pradesh, India, have successfully treated a severe drug-resistant bone infection using phage therapy. The patient, a 72-year-old…
The Korean Ministry of Health and Welfare’s “Infectious Disease Prevention and Treatment Technology Development Project” has selected Microbiotix to conduct the first Korean phage clinical trial.…
Recently, Amazon has published an article on Phagos. Phagos an AI tech-bio start-up company, has utilized Amazon Web Services(AWS) to develop an AI model. With this…
Moving away from the traditional “one-size-fits-all” approach to medicine, the precision medicine approach tailors treatment and prevention strategies to an individual’s unique characteristics, aiming to provide…
SNIPR Biome has conducted a randomized, double-blinded, placebo-controlled clinical trial. This is a Phase 1b clinical trial of SNIPR001 in patients with hematological cancer. These cancer…
Indian Council of Agricultural Research(ICAR) and Central Institute of Brackishwater Aquaculture(CIBA) signed a memorandum of Understanding(MoU) with M/s Salem Microbes Private Limited, Salem, Tamil Nadu, India, for…
The International Antiviral Society -USA has announced a 2.5-day conference on phages. Approximately 500 US and international attendees will be attending this conference. Being held from…
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a comprehensive new document aimed at guiding researchers and pharmaceutical companies in the safe development of…
Staphylococcus aureus bacteremia (SAB) is a bloodstream infection caused by Staphylococcus aureus, associated with significant morbidity and mortality. Staphylococcus aureus bacteremia (SAB) continues to be a major cause…